570 related articles for article (PubMed ID: 16835332)
1. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
2. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
3. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
4. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
[TBL] [Abstract][Full Text] [Related]
5. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
[TBL] [Abstract][Full Text] [Related]
6. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
Gong Z; Neuhouser ML; Goodman PJ; Albanes D; Chi C; Hsing AW; Lippman SM; Platz EA; Pollak MN; Thompson IM; Kristal AR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1977-83. PubMed ID: 17035408
[TBL] [Abstract][Full Text] [Related]
7. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
Dahle SE; Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Hsing AW
J Urol; 2002 Aug; 168(2):599-604. PubMed ID: 12131317
[TBL] [Abstract][Full Text] [Related]
8. Obesity and the risk of prostate cancer.
Porter MP; Stanford JL
Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
[TBL] [Abstract][Full Text] [Related]
9. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
[TBL] [Abstract][Full Text] [Related]
10. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
Freedland SJ; Terris MK; Platz EA; Presti JC
Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
[TBL] [Abstract][Full Text] [Related]
11. Assessment of 54 biomarkers for biopsy-detectable prostate cancer.
Parekh DJ; Ankerst DP; Baillargeon J; Higgins B; Platz EA; Troyer D; Hernandez J; Leach RJ; Lokshin A; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1966-72. PubMed ID: 17932343
[TBL] [Abstract][Full Text] [Related]
12. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
13. Obesity, adipokines and asthma.
Jartti T; Saarikoski L; Jartti L; Lisinen I; Jula A; Huupponen R; Viikari J; Raitakari OT
Allergy; 2009 May; 64(5):770-7. PubMed ID: 19210351
[TBL] [Abstract][Full Text] [Related]
14. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
Luc G; Empana JP; Morange P; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Evans A; Kee F; Bingham A; Machez E; Ducimetiere P
Int J Obes (Lond); 2010 Jan; 34(1):118-26. PubMed ID: 19823188
[TBL] [Abstract][Full Text] [Related]
15. Height, body weight, and risk of prostate cancer.
Giovannucci E; Rimm EB; Stampfer MJ; Colditz GA; Willett WC
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):557-63. PubMed ID: 9264267
[TBL] [Abstract][Full Text] [Related]
16. Anthropometrics and prostate cancer risk.
Littman AJ; White E; Kristal AR
Am J Epidemiol; 2007 Jun; 165(11):1271-9. PubMed ID: 17395597
[TBL] [Abstract][Full Text] [Related]
17. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Rodriguez C; Freedland SJ; Deka A; Jacobs EJ; McCullough ML; Patel AV; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):63-9. PubMed ID: 17179486
[TBL] [Abstract][Full Text] [Related]
18. Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study.
Platz EA; Leitzmann MF; Michaud DS; Willett WC; Giovannucci E
Cancer Res; 2003 Dec; 63(23):8542-8. PubMed ID: 14679023
[TBL] [Abstract][Full Text] [Related]
19. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
[TBL] [Abstract][Full Text] [Related]
20. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.
Kurahashi N; Iwasaki M; Inoue M; Sasazuki S; Tsugane S
J Clin Oncol; 2008 Dec; 26(36):5923-9. PubMed ID: 19018085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
